Your browser doesn't support javascript.
loading
Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
Hilfiker, Mark A; Wang, Ning; Hou, Xiaoping; Du, Zhimin; Pullen, Mark A; Nord, Melanie; Nagilla, Rakesh; Fries, Harvey E; Wu, Charlene W; Sulpizio, Anthony C; Jaworski, Jon-Paul; Morrow, Dwight; Edwards, Richard M; Jin, Jian.
Afiliação
  • Hilfiker MA; Department of Medicinal Chemistry, Metabolic Pathways Center of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, King of Prussia, PA 19406, United States. mark.a.hilfiker@gsk.com
Bioorg Med Chem Lett ; 19(15): 4292-5, 2009 Aug 01.
Article em En | MEDLINE | ID: mdl-19487124
ABSTRACT
This Letter discloses a series of 2-aminothiadiazole amides as selective EP(3) receptor antagonists. SAR optimization resulted in compounds with excellent functional activity in vitro. In addition, efforts to optimize DMPK properties in the rat are discussed. These efforts have resulted in the identification of potent, selective EP(3) receptor antagonists with excellent DMPK properties suitable for in vivo studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiadiazóis / Química Farmacêutica / Receptores de Prostaglandina E / Amidas Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiadiazóis / Química Farmacêutica / Receptores de Prostaglandina E / Amidas Idioma: En Ano de publicação: 2009 Tipo de documento: Article